Related Experiment Video
Updated: Jun 10, 2026
Cholesterol Efflux Assay
Published on: March 6, 2012
Effect of apoA-I on cholesterol release and apoE secretion in human mature adipocytes
Karima Bencharif1, Laurence Hoareau, Ravi K Murumalla
1LBGM-GEICO, Laboratoire de Biochimie et de Génétique Moléculaire - Groupe d'Etude sur l'Inflammation Chronique et l'Obésité, Plateforme CYROI, Université de La Réunion 15 avenue René Cassin 97715 Saint Denis Messag Cedex 9, France.
Insights
Human adipocytes release cholesterol, contributing to reverse cholesterol transport (RCT). Apolipoprotein A-I (apoA-I) enhances this process, highlighting adipose tissue
Area of Science:
- Cardiovascular Science
- Cell Biology
- Metabolic Research
Background:
- High-density lipoprotein cholesterol (HDL-c) levels inversely correlate with cardiovascular disease risk.
- Reverse cholesterol transport (RCT) mediated by HDL is crucial for anti-atherosclerotic activity.
- Adipose tissue is the largest reservoir of free cholesterol, implicating adipocytes in cholesterol homeostasis.
Purpose of the Study:
- To investigate cholesterol release capacity of human adipocytes.
- To explore relationships between apolipoprotein A-I (apoA-I), ABCA1, and apoE in adipocytes.
- To identify potential signaling pathways involved in adipocyte cholesterol regulation.
Main Methods:
- Primary cultures of mature human adipocytes were used.
- Cholesterol release and apolipoprotein secretion were measured.
- Effects of apolipoprotein A-I, brefeldin A, and statins were assessed.
Main Results:
- ApoA-I significantly increased cholesterol release and apoE secretion from adipocytes.
- ApoA-I did not alter the transcription of ABCA1 or apoE genes.
- Intracellular trafficking inhibition and statins did not affect apoA-I-induced cholesterol release.
Conclusions:
- Adipocytes significantly contribute to RCT through a cell-specific regulatory mechanism.
- Adipose tissue plays a major role in cardiovascular diseases, particularly atherosclerosis.
- Adipocytes are key regulators of cholesterol homeostasis and RCT.
Background:
The risk of cardiovascular disease is inversely correlated to level of plasma HDL-c. Moreover, reverse cholesterol transport (RCT) from peripheral tissues to the liver is the most widely accepted mechanism linked to the anti-atherosclerotic activity of HDL. The apolipoprotein A-I (apoA-I) and the ABC transporters play a key role in this process.Adipose tissue constitutes the body's largest pool of free cholesterol. The adipose cell could therefore be regarded as a key factor in cholesterol homeostasis. The present study investigates the capacity of primary cultures of mature human adipocytes to release cholesterol and explores the relationships between apoA-I, ABCA1, and apoE as well as the signaling pathways that could be potentially involved.
Results:
We demonstrate that apoA-I induces a strong increase in cholesterol release and apoE secretion from adipocytes, whereas it has no transcriptional effect on ABCA1 or apoE genes. Furthermore, brefeldin A (BFA), an intracellular trafficking inhibitor, reduces basal cholesterol and apoE secretion, but does not modify induction by apoA-I. The use of statins also demonstrates that apoA-I stimulated cholesterol release is independent of HMG-CoA reductase activation.
Conclusion:
Our work highlights the fact that adipose tissue, and particularly adipocytes, may largely contribute to RCT via a mechanism specifically regulated within these cells. This further supports the argument that adipose tissue must be regarded as a major factor in the development of cardiovascular diseases, in particular atherosclerosis.
